Home  /  Resource Library  /  Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation

Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation

Results of a study investigating venetoclax following allogeneic stem cell transplant in patients with CLL.